Claritev (CTEV) 10% Owner Ares Management LLC Buys $501K of Stock
Key Points
- Ares Management LLC bought 20,834 shares of Claritev Corporation at a price of $24.07 per share, totaling about $501,466.
- After the trade, Ares Management LLC indirectly holds 1,933,939 $CTEV shares, up 1.09% from before the trade.
- The stock closed at $21.54 on the day of the purchase and has recently traded around $22.65, up about 5.2% since then.
- Claritev Corporation is set to report its next earnings on November 9, 2026, following a recent revenue growth of 6.6% year-over-year.
Since the trade, $CTEV is up 5.2% to date (from the $21.54 close on Oct 26, 2026).
Get Claritev text alerts
We text you when insiders, Congress, analysts or big funds move on $CTEV.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Claritev Corporation alert may contain errors. Disclosures
On October 26, 2026, Ares Management LLC bought 20,834 shares of Claritev Corporation (CTEV) for about $501,466. The purchase price was $24.07 per share, which is higher than the stock's closing price of $21.54 on the same day, according to a Form 4 filing with the SEC.
CTEV
Claritev Corporation
What Changed in Ares Management LLC's Claritev Corporation Position
Ares Management LLC now holds a total of 1,933,939 shares in Claritev Corporation, reflecting a 1.09% increase in their ownership. This purchase comes as the company continues to navigate the healthcare sector, providing data analytics and cost management solutions.
Other Institutional Activity in Claritev Corporation
H&F Corporate Investors VIII, Ltd. continues to hold 3,887,858 shares of Claritev, valued at about $88.1 million. Ares Management LLC itself holds another 1,863,105 shares worth approximately $42.2 million. Other notable stakeholders include Arini Capital Management Ltd with 1,534,687 shares valued at around $34.8 million, and the Public Investment Fund with 1,281,250 shares worth about $29.0 million. Beach Point Capital Management LP reduced its stake by 20,037 shares, now holding 750,599 shares valued at about $17.0 million.
Claritev Corporation Stock Up 5.2%
As of October 27, 2026, Claritev Corporation's shares are trading around $22.65, which is above its 52-week low of $11.50 but significantly below its 52-week high of $73.68. The stock is currently below its 50-day moving average of $29.98 and its 200-day average of $25.82, indicating it has struggled to maintain higher price levels.
Recent Earnings
Claritev Corporation reported trailing twelve-month revenue of approximately $994.7 million, with a year-over-year revenue growth of 6.6%. However, the company has faced challenges with a net margin of -28.5% and an earnings per share of -$17.00. The next earnings report is scheduled for November 9, 2026.
Insider Buying and Selling at Claritev Corporation
Recently, CEO Travis Dalton purchased 6,450 shares on August 28, 2026, valued at about $249,664. These trades indicate a mix of buying and selling among the leadership team.
Analysts Set New Price Targets
On July 21, 2026, Canaccord Genuity maintained a Buy rating with a target price of $37.0. Citigroup also maintained a Buy rating on August 10, 2026, with a target of $45.0. Overall, analysts have a consensus target mean price of $46.0, reflecting confidence in the company's potential recovery.
About Claritev Corporation
Claritev Corporation, based in McLean, VA, offers data analytics and technology solutions aimed at cost management and revenue integrity in the healthcare industry. The company is navigating a challenging market but is backed by its institutional investors and analysts who see potential for growth.
Bottom Line
Investors should keep an eye on the upcoming earnings report on November 9, 2026, as well as any further insider trading activity. The recent purchase by Ares Management LLC may signal confidence in Claritev's future performance amid its current challenges.
Related Filing Alerts
Source: Ares Management LLC's Form 4 filing on $CTEV (Oct 26, 2026). Written by software, not financial advice. How we make alerts